logo

For the Inventor, By the Inventor

Grand Cayman, Cayman Islands

Maxygen Holdings Ltd.


USPTO Granted Patents = 19

% Expired Patents = 94.7


Forward Citations = 278

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Kim Vilbour Andersen (16 out of 47 patents)

silverMedal Christian Hansen (8 out of 13 patents)

bronzeMedal Anne Dam Jensen (7 out of 8 patents)

4.  Anders Pedersen (6 out of 20 patents)

5.  Torben Lauesgaard Nissen (5 out of 19 patents)

6.  Jan Moller Mikkelsen (5 out of 11 patents)

7.  Claus Bornaes (4 out of 16 patents)

8.  Hans Thalsgaard Schambye (4 out of 5 patents)

9.  Bart Van Den Hazel (2 out of 3 patents)

10.  Per Ola Freskgaard (2 out of 2 patents)

11.  Grethe Norskov Rasmussen (1 out of 25 patents)

12.  Carsten Germansen (1 out of 2 patents)

13.  Bobby Soni (1 out of 2 patents)

14.  Frank Bechnygaard (1 out of 1 patent)

15.  Frank Bech Nygaard (1 out of 2 patents)


19 patents:

1. 7550566 - G-CSF conjugates (2009-06-23),
2. 7550565 - G-CSF conjugates (2009-06-23),
3. 7524931 - Full-length interferon gamma polypeptide variants (2009-04-28),
4. 7504237 - Polynucleotides encoding interferon gamma polypeptides (2009-03-17),
5. 7442524 - Factor VII or VIIa-like molecules (2008-10-28),
6. 7427592 - Factor VII or VIIa - like molecules (2008-09-23),
7. 7419805 - Polynucleotides encoding S99T interferon gamma polypeptide variants and means of expression (2008-09-02),
8. 7414022 - Factor VII or VIIa-like molecules (2008-08-19),
9. 7390638 - S99T C-11 Truncated polynucleotides encoding interferon gamma polypeptide variants (2008-06-24),
10. 7381805 - Compositions comprising mixtures of positional PEG isomers of PEGylated G-CSF (2008-06-03),
11. 7371543 - Factor VII or VIIa-like molecules (2008-05-13),
12. 7232562 - E38N interferon gamma polypeptide variants (2007-06-19),
13. 7230081 - Interferon gamma conjugates (2007-06-12),
14. 7226999 - Protein C or activated protein C-like molecules (2007-06-05),
15. 7038015 - Interferon gamma polypeptide variants (2006-05-02),
Company Overview
Maxygen Holdings Ltd. is a biotechnology company based in Grand Cayman, specializing in the development and commercialization of innovative biopharmaceutical products. The organization focuses on leveraging advanced genetic engineering techniques to create novel therapeutics, particularly in the fields of oncology and autoimmune diseases. With a commitment to scientific excellence, Maxygen aims to address unmet medical needs through its cutting-edge research and development initiatives, contributing to the advancement of healthcare solutions globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

19 Patents

#43 in Grand Cayman

#54 in Cayman Islands

#32,663 in the World

Grand Cayman, KY
Grand Cayman, Cayman Islands

Maxygen Holdings Ltd.

Forward Citations = 278

16 inventors:

goldMedal Kim Vilbour Andersen (16 out of 47 patents)

silverMedal Christian Hansen (8 out of 13 patents)

bronzeMedal Anne Dam Jensen (7 out of 8 patents)

4.  Anders Pedersen (6 out of 20 patents)

5.  Torben Lauesgaard Nissen (5 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Maxygen Holdings Ltd.. Retrieved from https://idiyas.com/company/maxygen-holdings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…